PUTNEYMEAD GROUP MEDICAL PRACTICE — All Prescriptions & Medications — Page 6
Practice Code: H85012 | LONDON, SW15 6TQ
Showing results 251-300 of 667
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Lidocaine hydrochloride | 130 | 3,788 | £5.7K | -24.6% ▼ |
| 130 | 1,273 | £3.6K | +367.3% ▲ | |
| 130 | 76.4K | £900 | +42.6% ▲ | |
| Chlorphenamine maleate | 129 | 11.3K | £285 | +16.9% ▲ |
| Baclofen | 129 | 34.5K | £397 | -35.6% ▼ |
| Fenofibrate | 128 | 5,880 | £907 | +32.3% ▲ |
| 127 | 135 | £729 | +147.6% ▲ | |
| Fluconazole | 126 | 1,882 | £1.1K | +63.0% ▲ |
| Neomycin sulfate | 126 | 1,935 | £245 | +112.5% ▲ |
| Hydrocortisone acetate | 126 | 3,930 | £751 | +90.9% ▲ |
| Trospium chloride | 124 | 1,372 | £594 | +142.9% ▲ |
| Azithromycin | 122 | 2,373 | £904 | -3.8% ▼ |
| Galantamine | 119 | 1,575 | £3.3K | +214.5% ▲ |
| Sodium bicarbonate | 118 | 13.1K | £1.4K | +27.7% ▲ |
| Haloperidol | 117 | 2,742 | £16.7K | +145.6% ▲ |
| Pramipexole | 117 | 4,552 | £5.3K | +19.2% ▲ |
| Powder extensively hydrolysed formula (0913101) | 117 | 266.0K | £7.6K | +62.4% ▲ |
| Urea | 114 | 62.8K | £2.0K | +70.6% ▲ |
| Oxycodone hydrochloride | 113 | 15.7K | £3.1K | -55.8% ▼ |
| 113 | 8,966 | £1.3K | +65.0% ▲ | |
| Azathioprine | 112 | 9,380 | £212 | +3.3% ▲ |
| Terbinafine hydrochloride | 110 | 5,124 | £2.1K | +78.0% ▲ |
| Colchicine | 110 | 5,686 | £110 | +41.0% ▲ |
| Insulin Lispro | 109 | 559 | £4.5K | +42.5% ▲ |
| Metronidazole | 107 | 2,096 | £501 | +62.8% ▲ |
| Dorzolamide | 107 | 6,580 | £2.9K | +28.7% ▲ |
| Rizatriptan | 106 | 1,140 | £3.2K | +78.3% ▲ |
| Zolmitriptan | 106 | 1,429 | £6.4K | +63.3% ▲ |
| 106 | 27.6K | £1.7K | +4.4% ▲ | |
| Fesoterodine fumarate | 104 | 728 | £74 | +163.7% ▲ |
| Hypromellose | 104 | 1,470 | £288 | -21.5% ▼ |
| 104 | 1,120 | £392 | -50.2% ▼ | |
| Ascorbic acid | 103 | 1,792 | £2.2K | +401.6% ▲ |
| Mefenamic acid | 103 | 6,870 | £1.4K | +128.0% ▲ |
| 102 | 1,040 | £327 | +252.2% ▲ | |
| Vortioxetine | 101 | 3,688 | £3.5K | +45.5% ▲ |
| Mebeverine hydrochloride | 100 | 10.2K | £519 | -67.8% ▼ |
| Telmisartan | 100 | 5,600 | £1.1K | +72.5% ▲ |
| Betahistine hydrochloride | 99 | 12.0K | £443 | -58.5% ▼ |
| Flecainide acetate | 98 | 9,679 | £346 | +25.5% ▲ |
| Nicorandil | 98 | 2,500 | £349 | -31.9% ▼ |
| Desmopressin acetate | 98 | 6,342 | £4.9K | +87.9% ▲ |
| Clobazam | 97 | 8,887 | £3.2K | +47.1% ▲ |
| Temazepam | 96 | 2,479 | £2.2K | +67.8% ▲ |
| Celecoxib | 96 | 5,112 | £257 | +45.4% ▲ |
| Ranolazine | 95 | 7,888 | £1.4K | -44.1% ▼ |
| Methenamine hippurate | 94 | 6,084 | £1.6K | +3.3% ▲ |
| 94 | 1,327 | £1.2K | +153.7% ▲ | |
| 93 | 1,611 | £371 | +211.3% ▲ | |
| 91 | 9,300 | £658 | +30.4% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.